Off-Label Prescription Advertising, the FDA and the First Amendment: A Study in the Values of Commercial Speech Protection

被引：25
|
作者：
Klasmeier, Coleen [1 ]
Redish, Martin H. [1 ,2 ]
机构：
[1] Sidley Austin LLP, Washington, DC USA
[2] Northwestern Univ, Sch Law, Evanston, IL 60208 USA
来源：
AMERICAN JOURNAL OF LAW & MEDICINE | 2011年 / 37卷 / 2-3期
关键词：
D O I：
10.1177/009885881103700206
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
[No abstract available]
引用
收藏
页码：315 / 357
页数：43
相关论文
共 48 条
  • [41] The Commercial Speech Doctrine in Health Regulation: The Clash Between the Public Interest in a Robust First Amendment and the Public Interest in Effective Protection from Harm
    Orentlicher, David
    AMERICAN JOURNAL OF LAW & MEDICINE, 2011, 37 (2-3) : 299 - 314
  • [42] Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study
    Deng, Shuhua
    Zhu, Xiuqing
    Sun, Bin
    Hu, Jinqing
    Shang, Dewei
    Chen, Weijia
    Lu, Haoyang
    Ni, Xiaojia
    Zhang, Ming
    Wang, Zhanzhang
    Wen, Yuguan
    Qiu, Chang
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2018, 33 (03) : 172 - 179
  • [43] Safety and Efficacy of the Off-label Use of Pipeline Embolization Device Based on the 2018 FDA Approved Indications for Intracranial Aneurysms: A Single Center Retrospective Cohort Study
    Enriquez-Marulanda, Alejandro
    Penumaka, Anirudh
    Ogilvy, Christopher S.
    Thomas, Ajith J.
    Moore, Justin M.
    NEUROSURGERY, 2022, 68 : 91 - 91
  • [44] National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012)
    Blank, Mei-Ling
    Parkin, Lianne
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (02): : 179 - 184
  • [45] Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in EnglandResults of a Modified Prescription-Event Monitoring Study
    Miranda Davies
    Lynda Wilton
    Saad Shakir
    Drug Safety, 2013, 36 : 237 - 246
  • [46] Off-Label Prescription of Hydroxycarbamide (Hydroxyurea, HU) for Severe Anemia: Preliminary Results from European Non-Interventional, Multicentric, Prospective Escort-HU Study
    De Montalembert, Mariane
    Loko, Gylna
    Clouzeau, Jerome
    Brousse, Valentine
    Galacteros, Frederic
    Charneau, Corinne
    Belloy, Marie
    Benkerrou, Malika
    BLOOD, 2017, 130
  • [47] Pediatric off-label use of psychotropic drugs approved for adult use in Japan in the light of approval information regarding pediatric patients in the United States: a study of a pharmacy prescription database
    Nanae Tanemura
    Maika Asawa
    Mayuko Kuroda
    Tsuyoshi Sasaki
    Yoshiaki Iwane
    Hisashi Urushihara
    World Journal of Pediatrics, 2019, 15 : 92 - 99
  • [48] Pediatric off-label use of psychotropic drugs approved for adult use in Japan in the light of approval information regarding pediatric patients in the United States: a study of a pharmacy prescription database
    Tanemura, Nanae
    Asawa, Maika
    Kuroda, Mayuko
    Sasaki, Tsuyoshi
    Iwane, Yoshiaki
    Urushihara, Hisashi
    WORLD JOURNAL OF PEDIATRICS, 2019, 15 (01) : 92 - 99
12345